← Portfolio Scout

Portfolio company

Arpeggio Biosciences

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechB2B SaaS

About

The company provides a transcriptomics platform to map drug effects on gene expression for pharmaceutical and biotechnology partners developing novel therapeutics.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies